Advertisement
Screener

MEREO BIOPHARMA GROUP PLC (MREO) Deferred Tax Assets, Other

2.8 / 5 stars · 68/120 Roast Me

MEREO BIOPHARMA GROUP PLC Deferred Tax Assets, Other

MEREO BIOPHARMA GROUP PLC (MREO) had Deferred Tax Assets, Other of $9.00 thousand as of 2025-12-31, per its 10-K filed 2026-03-19.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsOther · last filed 2026-03-19

  • 2025-12-31: Deferred Tax Assets, Other $9.00K.
  • 2024-12-31: Deferred Tax Assets, Other $16.00K.
  • 2023-12-31: Deferred Tax Assets, Other $23.00K.
Period endDeferred Tax Assets, Other
2025-12-31$9.00K
10-K · filed 2026-03-19
2024-12-31$16.00K
10-K · filed 2026-03-19
2023-12-31$23.00K
10-K · filed 2025-03-26

Similar stocks

Stock NameCountryMarket CapPE Ratio
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78